G21.4

🧬 ICD-10-CM G21.4 — Vascular Parkinsonism

Billable Code Confirmed

ICD-10-CM G21.4 is a valid, billable 3-character ICD-10-CM code for FY2026. No further character subdivision is required — G21.4 is the complete, billable code. It is classified under G21 — Secondary Parkinsonism, within the G20-G26 Extrapyramidal and Movement Disorders block.

Code Also — Cerebrovascular Disease MUST Be Coded Additionally

The ICD-10-CM Tabular List carries a “Code also underlying cerebrovascular disease” instruction at G21.4. This is a mandatory coding requirement, not optional guidance. Every encounter where G21.4 is assigned must include an additional code for the underlying vascular pathology. The specific cerebrovascular code is determined by the physician’s documentation:

• Cerebral atherosclerosis / small vessel disease → I67.2
• Progressive vascular leukoencephalopathy (Binswanger) → I67.3
• Prior stroke with sequelae (most common) → appropriate I69.x code
• Acute/subacute poststroke VP → appropriate I63.x code
• Other cerebrovascular disease → I67.89

Submitting G21.4 alone without the required cerebrovascular code is incomplete coding and will generate a specificity audit flag.

G21.4 vs. Idiopathic PD (G20.x) — The Most Critical Differential in Parkinsonism Coding

G21.4 (vascular Parkinsonism) and the G20.A1/G20.A2/G20.B1/G20.B2 (idiopathic PD) codes are mutually exclusive — they represent fundamentally different disease entities and CANNOT be coded simultaneously. The distinction is not always straightforward at the bedside, but the coding implications are significant:

Feature	Vascular Parkinsonism (G21.4)	Idiopathic PD (G20.x)
Onset	Sudden (poststroke) or stepwise/insidious	Insidious, gradual
Body distribution	Lower body > upper body (“lower body parkinsonism”)	Upper body ≥ lower body; asymmetric early
Rest tremor	Absent or rare	Classic presenting feature
Levodopa response	Poor (30% partial response)	Robust and dramatic
Wearing-off / dyskinesia	ABSENT — no levodopa-related motor complications	Develops with long-term levodopa
DaTscan	Normal or abnormal (site-dependent)	Abnormal — reduced dopamine transporter uptake
MRI	White matter lesions, lacunar infarcts, basal ganglia infarcts	Often unremarkable or shows incidental changes
Dementia type	Vascular cognitive impairment / vascular dementia (F01.x)	Parkinson’s disease dementia (F02.x)

When documentation is ambiguous — or when a patient has BOTH cerebrovascular disease AND clinical features of idiopathic PD — the physician must clarify which condition is responsible for the parkinsonian features. A CDI query is mandatory when the record contains both vascular brain disease AND a Parkinson’s disease diagnosis without clear clinical attribution.

Code Classification

ICD-10-CM Diagnosis Code — Secondary Parkinsonism classified under G21. G21.4 is an etiology code — it represents the Parkinsonism condition. The “code also” instruction requires the underlying cerebrovascular disease to be coded additionally (sequencing of G21.4 vs. the cerebrovascular code depends on which condition is the principal diagnosis / reason for the encounter). For dementia associated with cerebrovascular disease in the context of vascular Parkinsonism, the appropriate dementia code is F01.x (vascular dementia) — NOT F02.x (Parkinson’s disease dementia), which is reserved for idiopathic PD-related dementia.

---

🔍 Code Description

ICD-10-CM G21.4 classifies vascular Parkinsonism (VP) — a secondary Parkinsonism syndrome caused by cerebrovascular disease, most commonly ischemic small vessel disease producing white matter damage and/or lacunar infarcts affecting the motor pathways subserving gait and balance. VP accounts for approximately 2.5-5% of all Parkinsonism cases and is a frequently underdiagnosed and misdiagnosed condition due to its resemblance to idiopathic Parkinson’s disease, the absence of definitive biomarkers, and the underestimation of cerebrovascular burden in older adults.

Unlike idiopathic PD — which results from dopaminergic neurodegeneration in the substantia nigra with Lewy body pathology — vascular Parkinsonism results from ischemic disruption of the motor circuits connecting the basal ganglia, thalamus, and motor cortex, primarily through: (1) white matter damage from chronic small vessel disease, disrupting thalamocortical and cortico-basal ganglia circuit connectivity; and (2) strategic lacunar infarcts in the basal ganglia, thalamus, or nigrostriatal pathway, directly impairing dopaminergic transmission. Lewy body pathology is typically absent. The dopamine transporter (DaT) SPECT scan may be normal (when VP is due to white matter disruption without nigral involvement) or abnormal (when lacunar infarcts directly affect nigrostriatal structures) — making DaTscan an important differentiating tool between VP and idiopathic PD in the diagnostic workup.

The clinical hallmark of VP is lower body Parkinsonism — a predominance of gait disorder, postural instability, freezing of gait, and falls, with relative sparing of the upper limbs and a characteristic absence of the classic pill-rolling rest tremor of idiopathic PD. This lower body distribution reflects the vascular etiology: subcortical white matter lesions predominantly affect the fiber tracts subserving lower extremity motor control. The poor response to levodopa (approximately 30% of VP patients show any levodopa benefit, compared to the dramatic and diagnostic levodopa response in idiopathic PD) is one of the most clinically important distinguishing features and directly impacts coding: because levodopa-related motor complications (wearing-off, dyskinesia) do not develop without dopaminergic terminal loss, G21.4 can NEVER be coded with G20.A2, G20.B1, or G20.B2 — wearing-off and dyskinesia do not occur in VP.

---

🌳 Code Tree / Hierarchy

G20-G26 Extrapyramidal and Movement Disorders  
│  
├── G20 — Parkinson's Disease (Idiopathic) — EXCLUDES1 from G21  
│ ├── G20.A1 ✅ Billable — Without dyskinesia, without fluctuations  
│ ├── G20.A2 ✅ Billable — Without dyskinesia, with fluctuations  
│ ├── G20.B1 ✅ Billable — With dyskinesia, without fluctuations  
│ ├── G20.B2 ✅ Billable — With dyskinesia, with fluctuations  
│ └── G20.C1 ✅ Billable — Parkinsonism, unspecified  
│  
├── G21 — Secondary Parkinsonism  
│ │ [Excludes1: Huntington's disease (G10); neurocognitive disorder  
│ │ with Lewy bodies (G31.83); Shy-Drager syndrome (G90.3);  
│ │ syphilitic Parkinsonism (A52.19)]  
│ │  
│ ├── G21.0 — Malignant neuroleptic syndrome ✅ Billable  
│ ├── G21.1 — Other drug-induced secondary parkinsonism ❌ Non-billable header  
│ │ ├── G21.11 — Neuroleptic induced Parkinsonism ✅ Billable  
│ │ └── G21.19 — Other drug induced secondary Parkinsonism ✅ Billable  
│ ├── G21.2 — Secondary Parkinsonism due to other external agents ✅ Billable  
│ ├── G21.3 — Postencephalitic Parkinsonism ✅ Billable  
│ ├── G21.4 — Vascular Parkinsonism ◀ THIS CODE ✅ Billable  
│ │ [Code also underlying cerebrovascular disease — MANDATORY]  
│ │ [Excludes1: Idiopathic PD (G20.x) — mutually exclusive]  
│ ├── G21.8 — Other secondary Parkinsonism ✅ Billable  
│ └── G21.9 — Secondary Parkinsonism, unspecified ✅ Billable  
│  
├── G22 — Parkinsonism in diseases classified elsewhere ✅ Billable  
├── G23 — Other degenerative diseases of basal ganglia  
│ ├── G23.1 — Progressive supranuclear palsy ✅ Billable  
│ ├── G23.3 — Striatonigral degeneration ✅ Billable  
│ └── G23.8 — Other specified degenerative diseases of basal ganglia ✅ Billable  
│  
└── G26 — Extrapyramidal and movement disorders in diseases elsewhere ✅ Billable

G20.C1 → G21.4 Upgrade When Vascular Etiology Confirmed

If a patient’s Parkinsonism was previously coded as G20.C1 (unspecified, etiology undetermined) and subsequent workup — MRI brain with white matter lesions, lacunar infarcts, DaTscan, or specialist documentation — confirms a vascular etiology, the code must be upgraded to G21.4 with the appropriate cerebrovascular “code also” companion. G20.C1 should never persist once etiology is established.

---

✅ Includes

The following clinical terms and scenarios map to G21.4 when the physician has documented vascular Parkinsonism or Parkinsonism attributable to cerebrovascular disease:

• Vascular Parkinsonism — physician explicitly documents this term
• Arteriosclerotic Parkinsonism — historical term for VP due to small vessel arteriosclerosis
• Multi-infarct Parkinsonism — Parkinsonism from multiple lacunar basal ganglia infarcts
• Lower body Parkinsonism due to cerebrovascular disease — when physician attributes lower body gait disorder/Parkinsonism to vascular cause
• Subcortical arteriosclerotic encephalopathy (Binswanger disease) with Parkinsonism — when physician documents both conditions
• Parkinsonism following stroke — acute/subacute VP where physician documents the stroke as causative (poststroke subtype)
• Parkinsonism due to white matter disease — when physician specifically attributes parkinsonian features to cerebrovascular white matter damage

Physician Attribution Is Required — MRI Alone Is Not Sufficient

The presence of white matter lesions or lacunar infarcts on MRI does NOT automatically justify assigning G21.4. These are extremely common incidental findings in older adults and are NOT sufficient for G21.4 assignment without physician documentation explicitly attributing the parkinsonian features to the vascular disease. The physician must state a clinical connection — “vascular Parkinsonism,” “Parkinsonism due to cerebrovascular disease,” “Parkinsonism from prior strokes” — before G21.4 can be coded.

---

❌ Excludes

Excludes 1 — Cannot Be Coded Simultaneously with G21.4

At the G21 Category Level

Code	Description	Note
G31.83	Dementia with Lewy bodies	Excludes1 from G21 category — DLB is a distinct alpha-synucleinopathy; mutually exclusive with secondary Parkinsonism coding
G90.3	Multi-system degeneration of the autonomic nervous system (Shy-Drager/MSA)	Excludes1 from G21 — MSA is a separate degenerative Parkinson’s-plus syndrome; not vascular in etiology
A52.19	Syphilitic Parkinsonism	Excludes1 from G21 — coded separately under infectious etiology

At the G21.4 Subcode Level — Idiopathic PD Codes

Code	Description	Note
G20.A1	PD without dyskinesia, without fluctuations	Mutually exclusive with G21.4 — idiopathic vs. vascular attribution must be established by physician; cannot code both simultaneously
G20.A2	PD without dyskinesia, with fluctuations	Mutually exclusive — wearing-off does not occur in vascular Parkinsonism
G20.B1	PD with dyskinesia, without fluctuations	Mutually exclusive — LID does not occur in vascular Parkinsonism
G20.B2	PD with dyskinesia, with fluctuations	Mutually exclusive — both LID and wearing-off are absent in vascular Parkinsonism
G20.C1	Parkinsonism, unspecified	Replaced by G21.4 once vascular etiology is confirmed

The Idiopathic PD + Vascular Brain Disease Coding Trap

The most common G21.4 coding compliance error is assigning both a G20.x idiopathic PD code AND G21.4 on the same encounter for a patient who has BOTH an established Parkinson’s disease diagnosis AND significant cerebrovascular disease on MRI. These codes are Excludes1 — mutually exclusive. Unless the physician explicitly documents TWO distinct and separately coexisting conditions (e.g., “patient has both idiopathic PD AND vascular Parkinsonism as co-contributing conditions”), only one Parkinsonism etiology should be coded. When the record is ambiguous, a CDI query for physician clarification of the primary etiology is mandatory before code assignment.

Additionally: a patient with idiopathic PD (G20.x) who ALSO has cerebrovascular disease documented (e.g., prior stroke, white matter changes) should have the cerebrovascular disease coded with I67.2 or I69.x — but this does NOT create a G21.4 code without physician attribution of the parkinsonian features to the vascular cause.

---

📋 Clinical Overview

The Three Subtypes of Vascular Parkinsonism

Per the international working group classification (PubMed 40471272, 2025), VP is divided into three clinical subtypes with distinct coding and documentation implications:

Subtype	Onset	Clinical Features	DaTscan	Levodopa	Most Common VP Code Companion
Subtype 1 — Poststroke (nigrostriatal)	Acute or subacute following stroke	Asymmetric Parkinsonism; dopamine deficiency due to direct nigrostriatal infarct; may respond to levodopa (~30%)	Abnormal (reduced DaT uptake)	Partial response in some	I63.x (acute) or I69.3x (sequelae of infarction)
Subtype 2 — Small vessel disease (white matter)	Insidious, stepwise progression	Bilateral symmetric; lower body predominance; broad-based gait; freezing; prominent postural instability; no rest tremor; urinary symptoms; pseudobulbar; dementia; poor levodopa response	Normal (nigra intact)	Poor to no response	I67.2 (atherosclerosis) or I67.3 (Binswanger)
Subtype 3 — Mixed VP/PD overlap	Variable	Features overlapping idiopathic PD and vascular; upper AND lower body; resting tremor may be present; moderate levodopa response	Abnormal	Variable	Requires physician clarification; G21.4 vs. G20.x vs. both — CDI query mandatory

Subtype 2 Is the Most Common — Lower Body Parkinsonism

The most clinically prevalent and frequently coded VP scenario is Subtype 2 — the insidious, slowly progressive lower body gait disorder from subcortical white matter ischemia. This is the classic presentation most neurologists refer to when documenting “vascular Parkinsonism”: shuffling gait, broad base, start hesitation, freezing, with relative preservation of arm swing and arm function, and a notable absence of rest tremor. The MRI shows periventricular and deep white matter hyperintensities on T2/FLAIR and lacunar infarcts. The DaTscan is typically normal — an important differentiator from idiopathic PD.

Clinical Features That Favor G21.4 Over G20.x

Clinical Feature	Favors G21.4 Vascular Parkinsonism	Favors G20.x Idiopathic PD
Rest tremor	Absent (rare)	Classic, prominent
Body distribution	Lower body > upper body	Upper body, asymmetric early
Levodopa response	Poor — no dramatic benefit	Robust, diagnostic-grade improvement
Levodopa motor complications	ABSENT — no wearing-off, no dyskinesia	Develop after years of therapy
DaTscan result	Normal (white matter subtype) or abnormal (nigrostriatal subtype)	Abnormal — reduced DaT uptake
MRI brain	White matter hyperintensities, lacunar infarcts, basal ganglia infarcts	Often normal or age-related changes
Onset pattern	Stepwise, sudden (poststroke), or insidious with vascular history	Insidious, asymmetric, progressive
Vascular risk factors	Prominent — HTN, DM, dyslipidemia, AF, smoking	Not etiologically related
Cognitive pattern	Vascular cognitive impairment / vascular dementia (F01.x)	Parkinson’s disease dementia (F02.x)
Autonomic dysfunction	Urinary incontinence prominent; less orthostatic hypotension	Orthostatic hypotension, constipation, hyperhidrosis

Treatment Principles for G21.4

Management of vascular Parkinsonism is fundamentally different from idiopathic PD — this has significant documentation and medical necessity implications:

Treatment Category	Approach in VP	Notes
Levodopa trial	Attempted in most patients; ~30% show partial response	If levodopa response is poor/absent, this supports VP diagnosis over idiopathic PD; document response explicitly
Vascular risk factor control	Cornerstone of VP management — HTN, DM, dyslipidemia, AF management; antiplatelet therapy; statins	Slows progression of white matter disease; primary disease-modifying approach for VP; no equivalent in idiopathic PD
Antiplatelet/anticoagulation	Per stroke prevention guidelines (AF → anticoagulation; atherosclerosis → antiplatelet)	Requires coding of the underlying vascular condition
Physical therapy / gait rehabilitation	Essential for functional maintenance; more responsive than pharmacotherapy	PT/OT/SLP referral documentation supports functional maintenance coding
Deep Brain Stimulation (DBS)	Generally NOT indicated for VP — no dopaminergic terminals to modulate via STN/GPi	Critical: DBS is a primary advanced therapy for idiopathic PD but is NOT standard of care for VP; documenting VP as G21.4 (not G20.x) prevents inappropriate DBS prior authorization use
LCIG/CLES or apomorphine infusion	NOT indicated for VP (no pulsatile levodopa effect; no wearing-off mechanism)	Same point — these advanced dopaminergic therapies are idiopathic PD-specific

G21.4 Documentation Prevents Inappropriate Advanced Therapy Billing

Because DBS, LCIG/CLES, and continuous subcutaneous apomorphine are indicated specifically for idiopathic PD motor complications (G20.A2/B1/B2), correct assignment of G21.4 — rather than a G20.x code — ensures that the coding record accurately reflects that these advanced dopaminergic therapies are NOT medically supported for this patient. Conversely, coding a VP patient with G20.B2 (both dyskinesia AND fluctuations) when the true diagnosis is G21.4 would fraudulently support DBS/LCIG prior authorization for a condition where those therapies are not indicated.

Dementia in Vascular Parkinsonism — F01.x, NOT F02.x

When dementia is present in a patient with vascular Parkinsonism, the appropriate dementia code family is F01.x (Vascular dementia) — NOT the F02.x (Dementia in other diseases) codes used for Parkinson’s disease dementia in idiopathic PD. This distinction is both clinically and coding-compliance important:

Dementia Type	Correct Code Series	Used With
Vascular dementia (in VP context)	F01.x — Vascular dementia	G21.4 — Vascular Parkinsonism
Parkinson’s disease dementia (in idiopathic PD)	F02.x — Dementia in other diseases	G20.A1/A2/B1/B2 — Idiopathic PD
Dementia with Lewy bodies	G31.83	Excludes1 from G21; cannot coexist

Documentation Requirements

For defensible and complete G21.4 assignment, the physician record should include:

1. Explicit attribution statement — physician must document “vascular Parkinsonism,” “arteriosclerotic Parkinsonism,” “Parkinsonism due to cerebrovascular disease,” or equivalent — MRI findings alone are not sufficient without clinical correlation
2. Specific cerebrovascular pathology identified — cerebral atherosclerosis, Binswanger disease, prior lacunar infarcts, prior stroke, or white matter disease documented as the causative vascular substrate
3. Poor or absent levodopa response noted — if levodopa was trialed; this supports VP over idiopathic PD
4. Absence of classic rest tremor — distinguishing clinical feature supporting VP
5. Vascular risk factor documentation — hypertension, diabetes, dyslipidemia, atrial fibrillation as contributing factors; each generates independent HCC opportunities
6. MRI/neuroimaging findings cited — T2/FLAIR white matter hyperintensities, lacunar infarcts, basal ganglia lesions supporting vascular substrate
7. DaTscan result if performed — normal result supports VP (white matter subtype); abnormal may suggest nigrostriatal subtype or concurrent idiopathic PD (→ CDI query)
8. Dementia documentation — if present, document as vascular dementia (F01.x) severity and behavioral disturbance — NOT F02.x

---

💰 HCC Risk Adjustment (CMS-HCC v28)

Field	Detail
CMS-HCC Model Version	v28 (100% Implementation FY2026)
HCC Assignment	✅ Mapped — HCC 155
HCC Category Name	Parkinson’s Disease and Huntington’s Disease
RAF Coefficient (Community Non-Dual Aged)	~0.372
G21.4 HCC vs. G20.x HCC	Both map to HCC 155 — no RAF difference at the G21 vs. G20 level
Compound HCC Profile	G21.4 patients carry a distinct and clinically rich compound HCC profile through their cerebrovascular comorbidities

G21.4 captures HCC 155 (Parkinson’s Disease and Huntington’s Disease, RAF ~0.372) — the same as idiopathic PD subcodes. The unique HCC opportunity at G21.4 is the compound cerebrovascular comorbidity stack — VP patients almost universally carry multiple vascular conditions that generate additional HCC weight:

The G21.4 Compound HCC Opportunity — Vascular Comorbidity Stack

At every G21.4 encounter, review and code ALL of the following when documented as active, monitored, or treated:

Cerebrovascular:

• I67.2 — Cerebral atherosclerosis → review HCC mapping
• I67.3 — Progressive vascular leukoencephalopathy (Binswanger) → review HCC mapping
• Stroke sequelae I69.x codes → multiple HCC tiers based on specific neurological deficit (hemiplegia, aphasia, dysphagia, ataxia)

Cardiac / Vascular Risk Factors:

• I48.11 / I48.19 / I48.20 — Atrial fibrillation → HCC 226
• I50.9 — Heart failure → HCC 225
• I25.10 — Atherosclerotic heart disease → review HCC mapping

Metabolic:

• E11.9 — Type 2 diabetes mellitus without complications → HCC 37
• E11.65 — Type 2 diabetes with hyperglycemia → review HCC mapping

Renal:

• N18.30 — CKD Stage 3 → HCC 327 range
• N18.4 — CKD Stage 4 → HCC 326 range

Cognitive / Dementia:

• F01.50-F01.C1 — Vascular dementia (severity and disturbance type) → HCC 127/126/125

A complete G21.4 encounter with all vascular comorbidities documented and coded can yield a substantially higher total RAF score than HCC 155 alone — the compound vascular HCC profile is the primary risk adjustment value driver in VP patients.

---

🏥 MS-DRG Assignment

MDC 01 — Diseases and Disorders of the Nervous System

DRG	Title	Est. Relative Weight*
DRG 056	Degenerative Nervous System Disorders with MCC	~2.23
DRG 057	Degenerative Nervous System Disorders without MCC	~1.30

*Approximate. Verify against IPPS FY2026 Final Rule tables. Only two DRGs in this pair — DRG 056 (MCC) and DRG 057 (no MCC).

Vascular Comorbidities Drive DRG 056 — Sequence Carefully

The rich vascular comorbidity profile of G21.4 patients provides multiple pathways to DRG 056 (with MCC). Key MCC-driving diagnoses at G21.4 inpatient encounters include:

• Severe vascular dementia — F01.C0 / F01.C1 (severe + behavioral disturbance) → MCC → DRG 056
• Aspiration pneumonia — J69.0 → MCC (dysphagia from pseudobulbar palsy is prominent in VP subtype 2)
• Acute respiratory failure — J96.01 → MCC
• Sepsis — A41.9 → MCC
• Stroke as principal — If an acute stroke is the reason for admission and VP is a secondary diagnosis, the DRG may shift to a stroke DRG (MDC 01 stroke DRGs — 061/062/063) rather than DRG 056/057

Sequencing note: When a patient with known VP is admitted for an acute stroke, the acute stroke (I63.x) typically sequences as principal — the G21.4 would be a secondary (comorbidity) code. Conversely, when admitted for VP management, falls, or gait deterioration without new acute stroke, G21.4 sequences as principal.

---

🔗 Related ICD-10-CM Codes

G21 Secondary Parkinsonism Family

Code	Description	Key Distinction from G21.4
G21.11	Neuroleptic induced Parkinsonism	Drug-induced (antipsychotic/metoclopramide); not vascular
G21.19	Other drug induced secondary Parkinsonism	Drug-induced; non-neuroleptic causative agent
G21.2	Secondary Parkinsonism due to other external agents	Environmental toxin etiology; MPTP, manganese
G21.3	Postencephalitic Parkinsonism	Encephalitis sequela; historical; von Economo’s encephalitis
G21.8	Other secondary Parkinsonism	Secondary causes not elsewhere classified
G21.9	Secondary Parkinsonism, unspecified	Secondary type confirmed but specific cause unknown

Mandatory “Code Also” Cerebrovascular Codes

Code	Description	Use When
I67.2	Cerebral atherosclerosis	Chronic small vessel cerebral atherosclerosis is the documented vascular substrate; most common companion code for VP Subtype 2
I67.3	Progressive vascular leukoencephalopathy (Binswanger disease)	Physician documents Binswanger disease or subcortical arteriosclerotic leukoencephalopathy
I67.89	Other cerebrovascular disease	When a more specific code does not apply
I69.398	Other sequelae of cerebral infarction	Parkinsonism as a specific sequela of prior cerebral infarction — use the appropriate I69.3xx subcode for the specific deficit
I63.00-I63.9	Cerebral infarction (various subtypes)	Acute/subacute poststroke VP when infarct is recent or acute

Atypical Parkinsonism — Must Be Distinguished from G21.4

Code	Description	When to Use Instead of G21.4
G23.1	Progressive supranuclear palsy (PSP)	PSP can mimic VP (gait disorder, falls, poor levodopa response) but has distinct MRI findings (hummingbird sign) and vertical gaze palsy; physician must document PSP
G23.3	Striatonigral degeneration (MSA-P)	MSA-Parkinsonian subtype — more prominent autonomic failure, cerebellar features; physician must document MSA
G90.3	Multi-system degeneration of the autonomic nervous system (MSA)	Excludes1 from G21; when physician documents MSA or Shy-Drager
G31.83	Dementia with Lewy bodies	Excludes1 from G21; DLB is a distinct alpha-synucleinopathy

Dementia in Vascular Parkinsonism Context

Code	Description	HCC v28
F01.50	Vascular dementia, unspecified severity, without behavioral disturbance	HCC 127
F01.A0	Vascular dementia, mild, without disturbance	HCC 127
F01.B0	Vascular dementia, moderate, without disturbance	HCC 126
F01.C0	Vascular dementia, severe, without disturbance	HCC 125
F01.51	Vascular dementia, unspecified severity, with behavioral disturbance	HCC 127
F01.B1	Vascular dementia, moderate, with behavioral disturbance	HCC 126
F01.C1	Vascular dementia, severe, with behavioral disturbance	HCC 125

Common Comorbidity Codes at G21.4 Encounters

Code	Description	Coding Relevance
I10	Essential (primary) hypertension	Most prevalent vascular risk factor in VP; active and treated; code at every encounter
E11.9	Type 2 diabetes mellitus without complications	Major vascular risk factor for small vessel disease; code with appropriate complication subcodes when present
I48.20	Chronic atrial fibrillation, unspecified	AF → cardioembolic stroke risk → poststroke VP Subtype 1; HCC 226; review specific AF subcode
E78.5	Hyperlipidemia, unspecified	Vascular risk factor; code at every encounter when active and treated
R13.19	Other dysphagia	Pseudobulbar palsy from subcortical vascular disease produces dysphagia in VP Subtype 2; drives aspiration precautions
J69.0	Pneumonitis due to inhalation of food and vomit (aspiration pneumonia)	MCC; consequence of VP-related dysphagia; more prevalent in VP Subtype 2 with pseudobulbar features
R26.89	Other abnormalities of gait and mobility	When gait disorder is the presenting symptom before VP is fully established; review if a more specific code applies once diagnosis is confirmed
W19.XXXA	Unspecified fall, initial encounter	Falls are the primary VP complication — postural instability, lower body Parkinsonism, and freezing of gait make VP one of the highest-fall-risk Parkinsonism syndromes
Z96.82	Presence of neurostimulator	Code when cardiac pacemaker or other stimulator (NOT DBS — DBS is not standard therapy for VP) is present; cardiac devices may affect MRI eligibility for workup

---

🛠️ Commonly Associated CPT Codes (Neurology)

Outpatient and Physician Setting Context

The CPT codes below are associated with the evaluation, management, and workup of vascular Parkinsonism in outpatient and physician fee schedule settings. Management is primarily vascular risk factor reduction, physical/occupational therapy, and gait rehabilitation — NOT advanced dopaminergic device therapies (DBS, LCIG, CSAI), which are idiopathic PD-specific.

CPT Code	Description	Clinical Application
99204	Office or other outpatient visit, new patient, moderate MDC	New patient neurology evaluation for new-onset lower body Parkinsonism / gait disorder suspected vascular etiology
99205	Office or other outpatient visit, new patient, high MDC	Complex new patient VP evaluation — multiple comorbidities, diagnostic planning (DaTscan, MRI, neuropsychological testing), advanced differential diagnosis formulation
99214	Office or other outpatient visit, established patient, moderate MDC	Follow-up VP management — levodopa response assessment, vascular risk factor review, fall risk evaluation, PT/OT referral
99215	Office or other outpatient visit, established patient, high MDC	Complex VP follow-up — cognitive decline, falls, multiple vascular comorbidity management, caregiver counseling, goals-of-care discussion
99483	Cognitive assessment and care plan services	Formal cognitive assessment — vascular dementia (F01.x) evaluation; distinguishing VP-associated cognitive impairment from PDD; modifier -25 required if same DOS as E/M
96132	Neuropsychological testing evaluation; first hour	Neuropsychological battery for VP differential diagnosis (VP executive dysfunction vs. idiopathic PD cognitive profile vs. PSP/MSA) and for vascular dementia staging
96133	+Neuropsychological testing evaluation; each additional hour	Add-on; never alone
96116	Neurobehavioral status exam; first hour	Office-based cognitive screen — MoCA, frontal assessment battery, MMSE for VP-associated vascular cognitive impairment
70553	MRI brain without and with contrast	Brain MRI — primary neuroimaging for VP workup; identifies white matter hyperintensities (T2/FLAIR), lacunar infarcts, subcortical atrophy, posterior fossa lesions
78607	Brain imaging, tomographic (SPECT)	DaTscan (dopamine transporter SPECT) — distinguishes VP subtype 1 (abnormal DaT from nigrostriatal infarct) from VP subtype 2 (normal DaT from white matter disease) and from idiopathic PD (abnormal DaT); critical differentiating study; append modifier -26 for professional interpretation only
95923	Testing of autonomic nervous system function	Autonomic function testing — relevant when MSA is in the differential vs. VP; MSA has prominent autonomic failure; VP autonomic features are less severe and urinary-predominant
97110	Therapeutic exercises	Physical therapy for VP gait rehabilitation — therapeutic exercise for lower extremity strength, balance, and gait training; billed by PT under outpatient therapy benefit
97116	Gait training therapy	Gait training — primary PT intervention for VP lower body parkinsonism; addresses shuffling, freezing, broad-based gait pattern

NCCI Bundling Considerations

NCCI PTP Edits — Verify Before Billing

• 99205 or 99214 and 96116 (neurobehavioral status exam) same DOS: modifier -25 required on the E/M when separately identifiable.
• 99483 (cognitive assessment) and standard E/M same DOS: modifier -25 required on the E/M; all 9 elements of 99483 must be documented.
• 78607 (DaTscan) — professional component (-26) applies when the neurologist interprets only; technical component (-TC) when facility performs only; global when same physician performs both.
• 96132 (neuropsychological testing) and 96116 (neurobehavioral status exam) same DOS: verify NCCI PTP edit status; must document each as independently medically necessary.
• Physical therapy codes (97110, 97116) are billed under the PT fee schedule — not by the neurologist — unless the neurologist is also providing physical therapy services directly.

---

🔬 ICD-10-PCS Crosswalk (Inpatient Procedures)

When G21.4 is an inpatient diagnosis, the following ICD-10-PCS sections are relevant. Unlike idiopathic PD, VP does NOT typically involve DBS, LCIG/J-tube, or apomorphine pump implantation.

PCS Section	Body System	Root Operation	Clinical Application
B (Imaging)	3 (Central Nervous System)	3 (MRI)	B030YZZ — MRI brain without contrast; B031YZZ — MRI brain with contrast; B032YZZ — MRI brain without and with contrast; VP diagnostic workup inpatient
C (Nuclear Medicine)	3 (Central Nervous System)	1 (Planar Nuclear Medicine Imaging)	DaTscan SPECT — dopamine transporter imaging; critical for VP vs. idiopathic PD differentiation; inpatient workup context
F (Physical Rehabilitation)	0 (Rehabilitation)	7 (Motor Treatment)	F07L0ZZ — Gait training; primary inpatient PT intervention for VP lower body Parkinsonism during acute care or inpatient rehabilitation
F (Physical Rehabilitation)	0 (Rehabilitation)	6 (Speech Treatment)	F06Z8ZZ — Swallowing rehabilitation for pseudobulbar dysphagia in VP Subtype 2
G (Mental Health)	Z (None)	3 (Psychological Tests)	GZ3ZZZZ — Neuropsychological testing for VP dementia workup and differential diagnosis (F01.x vs. F02.x)
0 (Medical & Surgical)	3 (Upper Arteries) or 4 (Lower Arteries)	Various	Vascular procedures if concurrent acute cerebrovascular intervention needed (thrombectomy, stenting) — concurrent acute stroke requiring intervention

---

💊 Coding Scenarios and Examples

---

Scenario 1 — Vascular Parkinsonism, Small Vessel Disease, Outpatient Follow-Up

Clinical Vignette: A 74-year-old male with history of hypertension, hyperlipidemia, and type 2 diabetes presents to neurology follow-up for progressive gait difficulty. MRI shows extensive periventricular and deep white matter hyperintensities and multiple small lacunar infarcts. Neurologist documents: “Vascular Parkinsonism due to cerebral small vessel disease / atherosclerosis. Poor levodopa response confirmed — discontinuing levodopa. Continue aggressive vascular risk factor management.”

CPT Codes:

• 99214 — Office visit, established patient, moderate MDC (VP management, medication discontinuation, vascular risk review)

ICD-10-CM:

• G21.4 — Vascular Parkinsonism (principal condition)
• I67.2 — Cerebral atherosclerosis (mandatory “code also” — documented cerebral small vessel atherosclerosis)
• I10 — Essential hypertension (active, treated)
• E78.5 — Hyperlipidemia, unspecified (active, treated)
• E11.9 — Type 2 diabetes mellitus, without complications (active, treated)

All Active Vascular Risk Factors Must Be Coded

At every G21.4 outpatient encounter, ALL documented, active, and treated vascular risk factors — hypertension, diabetes, dyslipidemia, atrial fibrillation — should be coded. These are not incidental; they are the etiological contributors to the VP and meet UHDDS criteria as conditions that affect patient care at the encounter. Each generates independent HCC value.

---

Scenario 2 — Poststroke Vascular Parkinsonism, Gait Disorder (Outpatient)

Clinical Vignette: A 68-year-old female with prior left basal ganglia lacunar infarct 8 months ago now presents with right-sided bradykinesia and gait disorder. Neurologist documents: “Vascular Parkinsonism as sequela of prior left basal ganglia infarction — nigrostriatal pathway involvement. DaTscan mildly abnormal bilaterally. Trial of levodopa in progress; partial response.”

CPT Codes:

• 99215 — Office visit, established patient, high MDC (complex VP evaluation, DaTscan interpretation, levodopa trial management)
• 78607 — Brain imaging, tomographic SPECT (DaTscan — professional interpretation); append modifier -26

ICD-10-CM:

• G21.4 — Vascular Parkinsonism (VP with documented nigrostriatal infarct etiology)
• I69.398 — Other sequelae of cerebral infarction (mandatory “code also” — VP as sequela of prior infarction; review for more specific I69.3xx subcode based on specific neurological deficit)

Poststroke VP — Sequela Code Not Acute Code

When VP develops as a neurological sequela of a prior stroke (not a new acute stroke), use the I69.x sequelae codes — NOT the I63.x acute cerebral infarction codes. The I69 sequela code reflects the chronic residual effect of the prior stroke that has now manifested as Parkinsonism. Per ICD-10-CM guidelines, sequela codes from I69.x may be used at any time after the acute phase — there is no time limit.

---

Scenario 3 — Vascular Parkinsonism With Vascular Dementia, DRG 056 (Inpatient)

Clinical Vignette: A 79-year-old male with vascular Parkinsonism (cerebral atherosclerosis, Binswanger disease) and moderate-to-severe vascular dementia with behavioral disturbance (agitation) is admitted for aspiration pneumonia from pseudobulbar dysphagia. MRI shows extensive white matter disease.

Principal Diagnosis:

• G21.4 — Vascular Parkinsonism (if VP and vascular dementia complications drive the admission; query physician for principal)

Additional Diagnoses:

• I67.3 — Progressive vascular leukoencephalopathy (Binswanger disease) (mandatory “code also” — documented Binswanger)
• F01.C1 — Vascular dementia, severe, with behavioral disturbance (MCC — severe vascular dementia with agitation)
• J69.0 — Aspiration pneumonia (MCC — direct complication of pseudobulbar dysphagia from white matter VP)
• R13.19 — Other dysphagia (supporting comorbidity — pseudobulbar dysphagia from subcortical vascular disease)
• I10 — Essential hypertension (active)
• E78.5 — Hyperlipidemia (active)

MS-DRG Assignment:

• DRG 056 — Degenerative Nervous System Disorders with MCC (F01.C1 and J69.0 are both MCCs)

Vascular Dementia in VP = F01.x, Never F02.x

Confirm that dementia in a VP patient is coded with F01.C1 (vascular dementia, severe, with behavioral disturbance) — NOT with F02.x (Parkinson’s disease dementia). F02.x is the manifestation code pair for idiopathic PD (G20.x) — using F02.x with G21.4 is a coding error that conflates vascular and idiopathic PD pathophysiology.

---

Scenario 4 — Ambiguous Parkinsonism: PD vs. VP — CDI Query Required

Clinical Vignette: An 80-year-old female is admitted. Problem list includes “Parkinson’s disease” from prior neurologist. Current hospitalist note documents: “Parkinsonism, bilateral gait disorder; MRI shows extensive white matter disease and lacunar infarcts.” No DaTscan in the record. Neurologist consulted — documents: “Parkinsonism — differential includes both idiopathic PD and vascular contributions. Will clarify after DaTscan.”

Coding Action:

• DO NOT assign both G20.A1 AND G21.4 — these are Excludes1
• Issue CDI query to the neurologist: “What is the primary etiology of this patient’s Parkinsonism — idiopathic Parkinson’s disease, vascular Parkinsonism, or both as separately coexisting conditions?”
• While awaiting clarification → assign G20.C1 (Parkinsonism, unspecified) as a holding code
• After neurologist clarifies:
  • Idiopathic PD confirmed → upgrade to G20.A1/A2/B1/B2 as appropriate
  • Vascular etiology confirmed → assign G21.4 + appropriate cerebrovascular “code also” companion
  • Both as coexisting: physician must explicitly document both conditions → assign both G20.x AND G21.4 ONLY with explicit dual-diagnosis physician documentation

---

⚠️ Coding Pitfalls and Tips

	Pitfall or Tip
❌	Never assign G21.4 based on MRI white matter lesions alone — MRI vascular changes are common in elderly patients and are NOT sufficient for G21.4 without physician documentation attributing the parkinsonian features to the vascular disease
❌	Never code G21.4 simultaneously with G20.A1/A2/B1/B2/C1 without explicit physician documentation of both conditions coexisting — these are Excludes1; the idiopathic vs. vascular attribution must be established by the physician
❌	Never assign G20.A2, G20.B1, or G20.B2 for vascular Parkinsonism — wearing-off and levodopa-induced dyskinesia DO NOT OCCUR in VP; if a patient coded as G21.4 has documented wearing-off or dyskinesia, a CDI query for idiopathic PD vs. vascular Parkinsonism attribution is mandatory
❌	Never omit the “code also” cerebrovascular companion — G21.4 submitted without a cerebrovascular code (I67.2, I67.3, I63.x, I69.x) is incomplete coding per ICD-10-CM Tabular instruction
❌	Never use F02.x for dementia in vascular Parkinsonism — F02.x (Parkinson’s disease dementia) is for idiopathic PD; vascular Parkinsonism-associated dementia codes to F01.x (vascular dementia)
❌	Never support DBS, LCIG, or CSAI prior authorization using G21.4 — these advanced therapies are indicated for idiopathic PD motor complications (G20.A2/B1/B2), not for vascular Parkinsonism; incorrect use of G21.4 to support DBS claims is a compliance and fraud risk
❌	Do not confuse G21.4 with G21.9 — G21.9 = secondary Parkinsonism with unidentified specific cause; G21.4 = secondary Parkinsonism specifically attributed to cerebrovascular disease; once vascular etiology is confirmed, G21.4 is the correct code — not G21.9
✅	Always issue a CDI query when a patient has both “Parkinson’s disease” on the problem list AND significant vascular brain disease on MRI — physician must clarify primary etiology before G20.x vs. G21.4 assignment
✅	Always code ALL active vascular risk factors — hypertension (I10), diabetes (E11.x), dyslipidemia (E78.5), atrial fibrillation (I48.x) are all UHDDS-codeable at every encounter and generate HCC value
✅	Code the specific cerebrovascular companion — prefer I67.2 (atherosclerosis), I67.3 (Binswanger), or appropriate I69.3x (infarction sequelae) over the generic I67.89 when documentation supports specificity
✅	DaTscan result informs VP subtype — document and code results: normal DaT → VP Subtype 2 (white matter); abnormal DaT → VP Subtype 1 (nigrostriatal) or possible coexistent idiopathic PD → CDI query
✅	Code dysphagia (R13.19) whenever documented — pseudobulbar dysphagia is prominent in VP Subtype 2; this drives aspiration precautions, SLP referral, and positions the case for DRG 056 capture via aspiration pneumonia (J69.0)
✅	Query for vascular dementia severity — F01.C0 / F01.C1 (severe) is MCC-level → DRG 056; active CDI querying for dementia severity is the highest-value documentation action at VP inpatient encounters
✅	Upgrade from G20.C1 to G21.4 when vascular workup is complete — never leave a VP patient coded as G20.C1 after the neurologist has confirmed vascular etiology

---

📚 Sources

1. CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026. Tabular List — G21.4 (Code also: underlying cerebrovascular disease); G21 category Excludes1 (Huntington’s G10, DLB G31.83, Shy-Drager G90.3, syphilitic A52.19); Sequela coding guidelines (Section I.C.9.d for cerebrovascular).

2. ACNR (Association for Clinicians of Neurological Rehabilitation). Vascular Parkinsonism: Clinical Features, Diagnosis. Published February 2026. VP subtypes; levodopa response data; vascular risk management; DaTscan utility.

3. PubMed. Vascular Parkinsonism: An Update. PubMed 40471272. July 2025. Three-subtype international working group classification; neuroimaging; molecular biomarkers; therapeutic options.

4. PMC/NIH. Vascular Parkinsonism: A Review on Management Updates. PMC6327701. Published 2018. Lacunar infarct pathology; basal ganglia involvement; levodopa response meta-analysis (30%).

5. PMC/NIH. Vascular Parkinsonism: Deconstructing a Syndrome. PMC4478160. Published 2015. Diagnostic criteria; strategic vs. non-strategic lesions; white matter disease threshold.

6. Cleveland Clinic. Vascular Parkinsonism: What It Is, Symptoms & Treatment. Published July 2025. Patient-facing clinical overview; treatment principles.

7. Medentic. ICD-10 G21.4: Vascular Parkinsonism. 2025. Code description; lower body parkinsonism definition.

8. AAPC Codify. ICD-10 Code G21.4 — Vascular Parkinsonism. G21 category structure; Excludes1 cross-references.

9. Palmetto GBA/PDAC. DRG 056, 057: Degenerative Nervous System Disorders. MDC 01; DRG 056 relative weight; MCC criteria.

10. CMS. 2026 Medicare Advantage CMS-HCC Model v28 — Final Risk Adjustment Coefficients. HCC 155 (Parkinson’s Disease and Huntington’s Disease).

11. CMS. IPPS Final Rule FY2026 — MS-DRG Definitions Manual v43. MDC 01; DRG 056/057.

12. AMA. CPT Professional Edition 2026. Neurology; DaTscan; neuropsychological testing; E/M guidelines.

13. CMS. NCCI Policy Manual for Medicare Services, current version.